Arthrosi Announces First Patient Dosed in Replicate Pivotal Phase 3 REDUCE 1 Trial of Lead Compound AR882
Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels, ...
Pharmabiz3d
Arthrosi Therapeutics doses first patient in replicate pivotal phase 3 REDUCE 1 trial of lead compound AR882
Arthrosi Therapeutics doses first patient in replicate pivotal phase 3 REDUCE 1 trial of lead compound AR882: San Diego Wednesday, March 19, 2025, 11:00 Hrs [IST] Arthrosi Therape ...
Woman's World on MSN4d
Early Gout Symptoms You Shouldn't Ignore-It's Not Just Big Toe Pain
If you've ever been going about your day only to get hit with excruciating joint pain, it could be gout. While this type of ...
Uric acid shows potential as new stroke treatment in preclinical study
In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The ...
The best shoes for gout, according to podiatrists
The best shoes for gout offer cushioning and support to help minimize discomfort during a flare-up. These are our ...
News-Medical.Net on MSN5d
Study shows potential of uric acid as add-on therapy for stroke
In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The findings suggest that the treatment may work as an add-on therapy to standard ...
Clinical Pain Advisor2d
Pro-Inflammatory Diet Linked to Increased Gout Risk in Women
Consuming a more anti-inflammatory diet may modulate systemic and metabolic inflammation, potentially reducing gout risk and its life-threatening comorbidities, particularly for women, who are ...